NCT06112132Completed
National Observatory of Children Hospitalized for Acute Respiratory Distress or Lower Respiratory Tract Infections
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
This study is an observational, multicenter and prospective study for surveillance of case of hospitalised children acute respiratory distress or lower respiratory tract infections
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1827 (actual)
- First submitted
- 27 Oct 2023
- Start date
- 27 Oct 2023
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- Association Clinique Thérapeutique Infantile du val de Marne
- Diseases
- Asthma
- NCT number
- NCT06112132
What you commit to
- Study type: Observational
- Participants enrolled: 1827
- From 27 Oct 2023 to the primary completion date, 30 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Refusal to participate by patient relative or legal representative
Who the study is looking for
- Children under 12 months of age for bronchiolitis or under 24 months of age for pneumonia or under 24 months of age for asthma
- Hospitalized in one of the 12 study sites
- From October 15, 2023
- For acute bronchiolitis or pneumonia or asthma defined according to current national and international recommendations
- Hospitalized from the pediatric emergency department.
Age in the registry: 1 day to 24 months · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ACTIV Coordinator of this site? Confirm its status | Créteil | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.